Treat-to-target urate-lowering therapy and hospitalisations for gout: results from a nationwide cohort study in England.

ULT associates with an increased risk of hospitalisations within the first 6 months of initiation but reduces hospitalisations in the long-term, particularly when serum urate targets are achieved.